A year before his murder, the Apotex founder had agreed to work with CannTrust to produce a slow-release medical marijuana pill that would treat chronic pain, depression, PTSD and more. Sherman and others felt the “pot pill” could be a game-changer in the industry and a disrupter to Big Pharma. “It makes sense,” Barry Sherman said to the executives around the boardroom table. “Let’s do it.” The project to develop a slow-release medical marijuana pill…
